#34: Jason: XOMA Rocks
XOMA has finally produced some good news! |
May 15, 2009
08:16:34 AM |
#33: Stock News Bot: XOMA Appoints John Varian to Board of Directors
BERKELEY, Calif., Dec. 11, 2008 (GLOBE NEWSWIRE) -- XOMA Ltd.
(Nasdaq:XOMA... |
December 22, 2008
11:04:45 AM |
#32: Stock News Bot: XOMA News Zacks Analyst Blog Highlights: Xoma, Novartis, Salix Pharmaceuticals and Shire Pharmaceuticals
CHICAGO--(BUSINESS WIRE)--Zacks.com announces the list of stocks featured in the... |
March 5, 2007
03:00:00 AM |
#31: Stock News Bot: XOMA News XOMA Successfully Completes Initial $15 Million BioDefense Contract with NIAID
BERKELEY, Calif.--(BUSINESS WIRE)--XOMA Ltd. (Nasdaq:XOMA) today announced that it... |
November 6, 2006
12:47:00 PM |
#30: Jason: XOMA on to something!
Is XOMA on to something that will result in big things for investors? I think so,... |
October 18, 2006
05:25:19 PM |
#29: Stock News Bot: XOMA News XOMA Announces Development Plan for XOMA 629 in Acne; Reformulation Efforts Successful; Clinical Trials Planned
BERKELEY, Calif.--(BUSINESS WIRE)--Sept. 7, 2006--XOMA Ltd. (Nasdaq:XOMA) today... |
September 7, 2006
06:00:00 AM |
#28: Stock News Bot: XOMA News XOMA's NEUPREX(R) Granted Orphan Status in Europe; XOMA Proceeding With Marketing Assessment
BERKELEY, Calif.--(BUSINESS WIRE)--Sept. 6, 2006--XOMA Ltd (Nasdaq:XOMA) announced... |
September 6, 2006
06:00:00 AM |
#27: Stock News Bot: XOMA News XOMA Unveils Strategy, Provides Update on NEUPREX(R); European Effort Advances Toward Orphan Drug Designation and Approval Under Exceptional Circumstances; US Trials Progress
BERKELEY, Calif.--(BUSINESS WIRE)--Aug. 15, 2006--XOMA Ltd. (Nasdaq:XOMA) today... |
August 15, 2006
06:00:00 AM |
#26: Stock News Bot: XOMA News XOMA Reports Second Quarter 2006 Results
BERKELEY, Calif.--(BUSINESS WIRE)--Aug. 9, 2006--XOMA Ltd. (NASDAQ:XOMA), a leader... |
August 9, 2006
01:00:00 PM |
#25: Stock News Bot: XOMA News XOMA Awarded New $16 Million BioDefense Contract with NIAID; Contracts Now Total $31 Million for XOMA to Produce Anti-Botulism Antibodies to Support Human Clinical Trials
BERKELEY, Calif.--(BUSINESS WIRE)--July 31, 2006--XOMA Ltd. (Nasdaq:XOMA) today... |
July 31, 2006
06:00:00 AM |
#24: Stock News Bot: XOMA News XOMA to Present at the Canaccord Adams 26th Annual Summer Seminar on August 8, 2006
BERKELEY, Calif.--(BUSINESS WIRE)--July 28, 2006--XOMA Ltd. (Nasdaq:XOMA)... |
July 28, 2006
01:35:00 PM |
#23: Stock News Bot: XOMA News XOMA Announces August 9 Conference Call and Webcast Discussion of Second Quarter 2006 Results
BERKELEY, Calif.--(BUSINESS WIRE)--July 28, 2006--XOMA Ltd. (Nasdaq:XOMA) will... |
July 28, 2006
01:26:00 PM |
#22: Stock News Bot: XOMA News XOMA Suspends HepeX-B(TM) Work Following Cubist Decision; XOMA in Talks with Cubist on HepeX-B Future
BERKELEY, Calif.--(BUSINESS WIRE)--July 28, 2006--XOMA Ltd. (Nasdaq:XOMA) today... |
July 28, 2006
01:17:00 PM |
#21: Stock News Bot: XOMA News XOMA to Receive New Royalty Stream From Bacterial Production License; LUCENTIS(TM) is First Approved Drug Licensed Under XOMA's BCE Program
BERKELEY, Calif.--(BUSINESS WIRE)--July 12, 2006--XOMA Ltd. (Nasdaq:XOMA) today... |
July 12, 2006
06:00:00 AM |
#20: Stock News Bot: XOMA News XOMA Expands U.S. Government Focus; XOMA Founder Dr. Patrick Scannon to Lead Effort
BERKELEY, Calif.--(BUSINESS WIRE)--July 11, 2006--XOMA Ltd. (Nasdaq:XOMA) today... |
July 11, 2006
10:11:00 AM |
